Login / Signup

Suvorexant alters dynamics of the sleep-electroencephalography-power spectrum and depressive-symptom trajectories during inpatient opioid withdrawal.

Matthew J ReidKelly E DunnLiza AbrahamJennifer Danielle EllisCarly HuntCharlene E GamaldoWilliam G CoonChung Jung MunEric C StrainMichael T SmithPatrick H FinanAndrew S Huhn
Published in: Sleep (2024)
Results highlight a complex and nuanced relationship between sleep-EEG power and symptoms of depression and withdrawal. Changes in delta power may represent a mechanism influencing depressive symptoms and withdrawal.
Keyphrases
  • depressive symptoms
  • sleep quality
  • social support
  • physical activity
  • pain management
  • functional connectivity
  • working memory
  • stress induced